Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Nanjing Aide Institute of Immunotherapy is a specialized research and development institution located in Nanjing, China, focused on the large-scale mapping of the human immune system. As a primary contributor to the global Human Immunome Project (H-IP), the institute utilizes high-throughput sequencing, single-cell analysis, and artificial intelligence to decode the complexities of immune repertoires. Its work aims to identify novel biomarkers and therapeutic targets to accelerate the development of precision vaccines and immunotherapies. The institute targets a wide range of conditions, including infectious diseases, oncology, and autoimmune disorders. By serving as a bridge between academic discovery and industrial application, it plays a pivotal role in the regional and global biotechnology ecosystem.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Nanjing Aide Institute of Immunotherapy.